Gail Page serves as Managing Partner of pH Blueprint, leveraging 35+ years of executive experience and networks to benefit clients in the diagnostic and clinical laboratory spaces. Gail is an accomplished public CEO, leading Vermillion and Chembio through industry-defining pivots and product launches.
She is a seasoned executive leader with notable tenures at LabCorp, Luminex, and Vermillion. Gail has been instrumental in raising over $175M in public and private funding.
Her current board appointments include Sword Bio, Inc, Mellitus, LLC, and MARAbio. In addition to the above, she serves as a Venture Partner for Turret Capital.